Neuropharmacology print books and ebooks | Elsevier

Pathophysiology, Pharmacology and Biochemistry of Dyskinesia

1st Edition
Volume 98
September 7, 2011
Jonathan Brotchie + 2 more
English
eBook
9 7 8 0 1 2 3 8 1 3 2 9 9

Published since 1959, International Review of Neurobiology is a well-known series appealing to neuroscientists, clinicians, psychologists, physiologists, and pharmacologists. Led by an internationally renowned editorial board, this important serial publishes both eclectic volumes made up of timely reviews and thematic volumes that focus on recent progress in a specific area of neurobiology research. This volume reviews existing theories and current research surrounding the movement disorder Dyskinesia.

Pharmacology of 5-HT6 receptors, Part I

1st Edition
Volume 94
November 29, 2010
Franco Borsini
English
eBook
9 7 8 0 1 2 3 8 4 9 7 7 9

The serotonin 5-HT6 receptor represents a novel pharmacological target whose impact on physiopathology of CNS functions remains undetermined. Some receptor antagonists have been synthesized and they show a modulatory role in learning and memory processes and food intake. The pharmacology of 5-HT6 receptor agonists is still under evaluation. However, both 5-HT6 antagonists and agonists seem to exert potential antidepressant activity. Recently, a second messenger system has been discovered. 5-HT6 receptor function is becoming more and more intriguing. Thus, the aim of the present book is to try to clarify the pharmacology of 5-HT6 receptors.

GABAb Receptor Pharmacology: A Tribute to Norman Bowery

1st Edition
Volume 58
August 4, 2010
Thomas P. Blackburn
English
Hardback
9 7 8 0 1 2 3 7 8 6 4 7 0
eBook
9 7 8 0 1 2 3 7 8 6 4 8 7

This monograph was assembled to honor Professor Norman Bowery and his work on the 30th anniversary of his discovery of the GABAB receptor. In the present volume, leading neuroscientists from academia and industry provide a perspective of current research, both basic and translational, in the discovery of drugs acting at the GABAB receptor. The topics covered provide a comprehensive review of the field and the current state of research in this area. Included are chapters on the chemistry of GABAB agonists and antagonists, on the genetics and molecular composition of the site, its regulation and trafficking, and its role in controlling cellular, autonomic, and behavioral function. There are also chapters describing the potential clinical utility of drugs regulating GABAB activity receptor in the areas of hypertension, gastroesophageal reflux disease, Down syndrome, depression, and substance abuse. The information contained in this text will be of particular interest to neuroscientists in general and to neuropharmacologists in particular.

Nanoneuroscience and Nanoneuropharmacology

1st Edition
Volume 180
December 3, 2009
Hari S. Sharma
English
Hardback
9 7 8 0 4 4 4 5 3 4 3 1 6
eBook
9 7 8 0 0 8 0 9 6 2 2 4 5

This volume presents articles from the leading experts in the field in nanobiotechnology, providing students and researchers with a comprehensive review of the newly emerging area of neuroscience. All aspects of nanomaterials induced alteration in brain function are considered. Basic chapters on methods and ways to enhance nano-drug delivery into the brain are presented as well as chapters on functional and structural changes in the CNS, including gene expression and related issues. Particular attention is given to possible therapeutic advancement regarding nano-drug formulation and their role in neuroprotection.

Advances in Neuropharmacology

1st Edition
Volume 85
July 30, 2009
Giacinto Bagetta + 3 more
English
Hardback
9 7 8 0 1 2 3 7 4 8 9 3 5
eBook
9 7 8 0 0 8 0 9 5 3 8 6 1

This volume provides a broad overview of important new advances in the field of Neuropharmacology. In 20 chapters, a selection of international contributors discuss topics including endocannabinoid function, pain, stress, astrocytes etc, and new possibilities for treatments of neurological diseases with neuropharmacological approaches.

Pharmacology

1st Edition
June 19, 2009
Miles Hacker + 2 more
English
Hardback
9 7 8 0 1 2 3 6 9 5 2 1 5
eBook
9 7 8 0 0 8 0 9 1 9 2 2 5

Pharmacology meets the rapidly emerging needs of programs training pharmacologic scientists seeking careers in basic research and drug discovery rather than such applied fields as pharmacy and medicine. While the market is crowded with many clinical and therapeutic pharmacology textbooks, the field of pharmacology is booming with the prospects of discovering new drugs, and virtually no extant textbook meets this need at the student level. The market is so bereft of such approaches that many pharmaceutical companies will adopt Hacker et al. to help train new drug researchers. The boom in pharmacology is driven by the recent decryption of the human genome and enormous progress in controlling genes and synthesizing proteins, making new and even custom drug design possible. This book makes use of these discoveries in presenting its topics, moving logically from drug receptors to the target molecules drug researchers seek, covering such modern topics along the way as side effects, drug resistance, pharmacogenomics, and even nutriceuticals, one in a string of culminating chapters on the drug discovery process. The book is aimed at advanced undergraduates and beginning graduate students in medical, pharmacy, and graduate schools looking for a solid introduction to the basic science of pharmacology and envisioning careers in drug research.

Chemical Factors in Neural Growth, Degeneration and Repair

1st Edition
December 17, 1996
C. Bell
English
eBook
9 7 8 0 0 8 0 5 2 9 0 3 5

This volume provides an up-to-date survey of current thinking concerning the actions of chemical factors in the regulation of neuronal behaviour under normal and pathological conditions. The book is divided into four sections, dealing with chemical factors involved with the formation of axon pathways, factors involved with neuronal survival and specialization during normal development, factors involved in normal maintenance and repair of adult neurons and, finally, factors that have been implicated as mediators of degenerative changes in neurological and neuropsychiatric disorders.

Neuropeptide Y and Drug Development

1st Edition
November 15, 1996
Lars Grundemar + 1 more
English
Hardback
9 7 8 0 1 2 3 0 4 9 9 0 2
eBook
9 7 8 0 0 8 0 5 3 7 4 5 0

Neuropeptide Y (NPY) is a ubiquitous and important messenger in the nervous system, with a wide range of physiological roles. It is involved in the body energy balance and is one of the most potent stimuli of food intake known. NPY also acts to regulate central and peripheral autonomic functions. This book, written by academic and industrial experts in the field, links the most recent basic experimental knowledge about NPY and its receptors with areas of clinical importance. This book will be of interest to those working in all areas of research affected by NPY, such as food intake and energy homeostasis, cardiovascular regulation and G-protein-coupled receptors, as well as those interested in the development of drugs as NPY targets.

Neurotransmitter Receptors

1st Edition
Volume 24
March 17, 1994
F. Hucho
English
eBook
9 7 8 0 0 8 0 8 6 0 8 4 8

This comprehensive compilation provides a wealth of information on receptor sequences produced by recombinant DNA techniques used in combination with classical biochemistry. To minimize redundancies in this wealth of information, only a few receptors (some of which are typical for a whole group of similar receptors, others which are presently of special interest) are dealt with in a full-size chapter. Others are represented in the TIPS Receptor Nomenclature Supplement which is included as a special feature in this book, making this volume more useful as a receptor handbook.

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Books in Neuropharmacology